Jazz Pharmaceuticals
JAZZ
#2121
Rank
S$10.21 B
Marketcap
$168.93
Share price
-0.54%
Change (1 day)
2.70%
Change (1 year)

EPS for Jazz Pharmaceuticals (JAZZ)

EPS in 2023 (TTM): -$1.91

According to Jazz Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$1.92. In 2022 the company made an earnings per share (EPS) of -$4.81 an increase over its 2021 EPS that were of -$7.31.

EPS history for Jazz Pharmaceuticals from 2005 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.91-60.35%
2022-$4.81-34.2%
2021-$7.31-224.83%
2020$5.85-53.25%
2019$12.5223.59%
2018$10.13-8.24%
2017$11.0423.74%
2016$8.9222.12%
2015$7.31478.49%
2014$1.26-74.93%
2013$5.04-27.11%
2012$6.9169.1%
2011$4.09245.98%
2010$1.18-462.5%
2009-$0.33-96.7%
2008-$9.89-27.04%
2007-$13.5565.47%
2006-$8.19-4.59%
2005-$8.58

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$5.46 185.11%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
$11.26-687.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.08-365.25%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
-$2.72 41.84%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel